Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

Name: Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Starting Price : $5000.00 $3500.00 | Pages : 262 | Published : January 2022 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Brain Tumor Drugs Market Definition

The brain tumor drugs market consists of sales of brain tumor drugs and related services by entities (organizations, sole traders and partnerships) that produce brain tumor drugs to diagnose and cure a mass growth of abnormal cells in the human brain. These drugs are either used alone or in combinations, depending on the type, size and location of the tumor. For example, Afinitor (Everolimus), BiCNU (Carmustine), Everolimus, Carmustine, Temozolomide and Avastin (Bevacizumab) are some of the drugs included in this market.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing. Brain tumor drugs manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Book your 30 minutes free consultation with our research experts

Brain Tumor Drugs Market Size

The global brain tumor drugs market reached a value of nearly $5,656.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.5% since 2015. The brain tumor drugs market is expected to grow from $5,656.4 million in 2020 to $9,128.1 million in 2025 at a rate of 10%. The brain tumor drugs market is then expected to grow at a CAGR of 8.8% from 2025 and reach $13,932 million in 2030.

Growth in the historic period in the brain tumor drugs market resulted increasing prevalence of neurological disorders, increased healthcare expenditure, increased number of approvals for oncology (cancer) drugs, increase in pharmaceutical R&D expenditure, and advances in cancer drug discovery. The brain tumor drugs market was restrained increasing use of targeted therapies, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.

Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs, and revised FDA regulations to facilitate biologics drug development. Factors that could hinder the growth of the brain tumor drugs market in the future include high costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, and coronavirus pandemic.

Brain Tumor Drugs Market Drivers

The key drivers of the brain tumor drugs market include:

Increase In Brain Tumor Incidence Rate

The rise in the number of brain tumor cases across the globe is likely to contribute to the growth of the brain tumor drugs market during the forecast period. Brain tumors account for 85% to 90% of all primary central nervous system (CNS) tumors. According to the American Cancer Society, in 2021, nearly 24,530 malignant brain tumors cases will be diagnosed in the USA and around 18,600 people are expected to die from the same. Brain tumor have a survival rate is just 5 year. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for brain tumor drugs market over the forthcoming years.

Brain Tumor Drugs Market Restraints

The key restraints on the brain tumor drugs market include:

High Costs of Drugs

High costs associated with anti-cancer drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. The drug from NextSource Biotechnology is used to treat glioblastoma and other brain tumors and can cost as much as $1,000 a capsule. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of brain tumor drug manufacturers.

Brain Tumor Drugs Market Trends

Major trends influencing the brain tumor drugs market include:

Combination Of Drugs To Help With Treatment

Companies operating in the brain tumor drugs market are increasingly adopting the use of a combination of drugs to treat a brain tumor. In 2021, a combination of two medicines is being tested as a therapy for glioblastoma, an aggressive kind of brain cancer. These medicines work by allowing the immune system to focus on the tumor. Two patients in a phase 1 clinical study have shown encouraging outcomes. For example, trials conducted by UCSF Benioff Children’s Hospitals in 2018 show personalized drug cocktails to treat aggressive brain tumors in children offers new strategies in the treatment for high-grade glioma and increases chances of survival.

Adapting Phase Zero Clinical Trials

Companies operating in the brain tumor drugs market are focusing on clinical trials of new drugs. Drug discovery and medicinal chemistry are in an era of productivity and innovation. The rush of new experimental drugs for brain tumors faces obstacles that can be avoided with a more efficient system such as the phase 0 clinical trial. Phase 0 trials are generally conducted amongst fewer patients and uses small doses of a new drug to help identify which new therapies warrant accelerated development and, which new therapies are destined for failure by asking the questions in human modes rather than the usual animal mode. For example, in ABT-888 phase 0 trial which was oncology’s first phase 0 trial, peripheral blood mononuclear cells (PBMCs) were used as surrogate tissue.

Opportunities And Recommendations In The Brain Tumor Drugs Market

Opportunities –The top opportunities in the brain tumor drugs market segmented by drugs will arise in the others segment, which will gain $2,494.7 million of global annual sales by 2025. The top opportunities in the brain tumor drugs market segmented by end-user will arise in hospital pharmacies segment, which will gain $1,804.9 million of global annual sales by 2025.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the brain tumor companies to focus on combination of drugs to help with treatment, adopt phase zero clinical trials, focus on nanotechnology for drug delivery and tumor treatment, focus on expansion of cell and gene therapy & CAR-T for brain tumors, expanding in emerging markets, set up authorized distributors and sales representatives, bundled payments, skimmed pricing, adopt premium pricing, participate in trade shows and events, increase visibility through business websites and listing websites, use big data analytics to improve marketing activities, targeting hospitals and pharmacies to spread awareness, and targeting the geriatric population.

Brain Tumor Drugs Market Segmentation

The brain tumor drugs market is segmented by drugs and by end-user.
By Drugs -
The brain tumor drugs market is segmented by drugs into:

a) Temozolomide
b) Bevacizumab
c) Others

The others was the largest segment of the brain tumor drugs market segmented by drugs, accounting for 69.3% of the total in 2020. Going forward, the Temozolomide segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by drugs, at a CAGR of 15.2% during 2020-2025.
By End User -
The brain tumor drugs market is segmented by end user into:

a) Hospital Pharmacies
b) Retail Pharmacies
c) Other End-Users

The hospital pharmacies market was the largest segment of the brain tumor drugs market segmented by end-user, accounting for 53.4% of the total in 2020. Going forward, the other end-users segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by end-user, at a CAGR of 11.1% during 2020-2025.
By Geography – The brain tumor drugs market is segmented by geography into

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

Asia Pacific was the largest region in the brain tumor drugs market, accounting for 31.8% of the total in 2020. It was followed by the North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the brain tumor drugs market will be Asia Pacific and Western Europe where growth will be at CAGRs of 11.8% and 9.9% respectively during 2020-2025. These will be followed by South America and North America, where the markets are expected to register CAGRs of 9.4% and 9.1% respectively during 2020-2025.

Brain Tumor Drugs Competitive Landscape

Major Competitors are:

F. Hoffmann-La Roche Ltd

Novartis AG

Amgen Inc.

Pfizer Inc.

Merck & Co. Inc.

Other Competitors Include:

CordenPharma

Eisai Co., Ltd.

Emcure Pharmaceuticals Limited

AstraZeneca

Y-mAbs Therapeutics

Roche India

Novartis Oncology

Arlak Biotech

Healthkind labs Pvt. Ltd.

SwisscheM Healthcare Pvt.Ltd

Apikos Pharma

Kolaz biotech.

CStone Pharma

CARsgen Therapeutics

JW Therapeutics

BeiGene

Takeda Pharmaceuticals

Astellas Pharma Inc

Otsuka Pharmaceutical Co., Ltd

Daiichi Pharmaceutical and Sankyo

AQVIDA GmbH

Baxter International Inc

AstraZeneca plc

GlaxoSmithKline plc

F. Hoffmann-La Roche AG

Veropharm

Biocad

Roche

Bristol-Myers Squibb

Celon Pharma

Celgene Corporation

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Eli Lilly and Company

Merck

Pfizer

Amgen

AstraZeneca

Bayer AG

Novartis AG

Sandoz AG (A Novartis Division)

Eurofarma Laboratórios S.A.

GlaxoSmithKline plc

TUTEUR Argentina

The Takeda Pharmaceutical Company Limited

Pierre Fabre Group

Celnova Pharma

Pfizer S.R.L.

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

BIOPHARMA-MEA

NeoTX

AID Genomics Limited

Novartis AG

GlaxoSmithKline plc

Pfizer

Merck Sharp & Dohme Corp. (Merck & Co., Inc.)

Julphar

Sanofi

Bayer

Kitov Pharma Limited

CureTech Ltd.

Neopharma

Eurolab

Aspen

Adcock Ingram

1. Brain Tumor Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1. Segmentation By Geography

7. Brain Tumor Drugs Market Characteristics

7.1. Market Definition

7.2. Market Segmentation By Drugs

7.2.1. Temozolomide

7.2.2. Bevacizumab

7.2.3. Others

7.3. Market Segmentation By End-User

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies/Drug Stores

7.3.3. Other Pharmacies

8. Brain Tumor Drugs Market Trends And Strategies

8.1. Combination Of Drugs To Help With Treatment

8.2. Adapting Phase Zero Clinical Trials

8.3. Nanotechnology For Drug Delivery And Tumor Treatment

8.4. Expansion Of Cell And Gene Therapy & CAR-T For Brain Tumors

8.5. Increasing Mergers And Acquisitions

9. Impact Of COVID-19 On Brain Tumor Drugs Market

9.1. Clinical Trial Delays

9.2. Low Usage Of Drugs

9.3. Supply Chain Issues

9.4. Shortage In Resources

9.5. Impact on Patients

9.6. Future Outlook

10. Global Brain Tumor Drugs Market Size And Growth

10.1. Market Size

10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

10.2.1. Drivers Of The Market 2015 – 2020

10.2.2. Restraints On The Market 2015 – 2020

10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

10.3.1. Drivers Of The Market 2020 – 2025

10.3.2. Restraints On The Market 2020 – 2025

11. Global Brain Tumor Drugs Market Segmentation

11.1. Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.2. Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12. Brain Tumor Drugs Market, Regional And Country Analysis

12.1. Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.2. Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Brain Tumor Drugs Market

13.1. Asia-Pacific Brain Tumor Drugs Market Overview

13.1.1. Region Information

13.1.2. Impact Of COVID-19

13.1.3. Market Information

13.1.4. Background Information

13.1.5. New Drug Approvals

13.1.6. Government Initiatives

13.1.7. Regulations

13.1.8. Regulatory Bodies

13.1.9. Major Associations

13.1.10. Taxes Levied

13.1.11. Corporate Tax Structure

13.1.12. Investment

13.1.13. Major Companies

13.2. Asia-Pacific Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.3. Asia-Pacific Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.4. Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.5. Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.6. Asia-Pacific Brain Tumor Drugs Market: Country Analysis

13.7. China Brain Tumor Drugs Market

13.8. China Brain Tumor Drugs Market Overview

13.8.1. Country Information

13.8.2. Impact Of COVID-19

13.8.3. Market Information

13.8.4. Background Information

13.8.5. New Drug Approvals

13.8.6. Government Initiatives

13.8.7. Regulations

13.8.8. Regulatory Bodies

13.8.9. Major Associations

13.8.10. Taxes Levied

13.8.11. Corporate Tax Structure

13.8.12. Investment

13.8.13. Major Companies

13.9. China Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.10. China Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.11. China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.12. China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.13. India Brain Tumor Drugs Market

13.14. India Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.15. India Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.16. India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.17. India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.18. Japan Brain Tumor Drugs Market

13.19. Japan Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.20. Japan Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.21. Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.22. Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.23. Australia Brain Tumor Drugs Market

13.24. Australia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.25. Australia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.26. Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.27. Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.28. Indonesia Brain Tumor Drugs Market

13.29. Indonesia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.30. Indonesia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.31. Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.32. Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.33. South Korea Brain Tumor Drugs Market

13.34. South Korea Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.35. South Korea Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.36. South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.37. South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Brain Tumor Drugs Market

14.1. Western Europe Brain Tumor Drugs Market Overview

14.1.1. Region Information

14.1.2. Impact Of COVID-19

14.1.3. Market Information

14.1.4. Background Information

14.1.5. New Drug Approvals

14.1.6. Government Initiatives

14.1.7. Regulations

14.1.8. Regulatory Bodies

14.1.9. Major Associations

14.1.10. Taxes Levied

14.1.11. Corporate Tax Structure

14.1.12. Investment

14.1.13. Major Companies

14.2. Western Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.3. Western Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.4. Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.5. Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.6. Western Europe Brain Tumor Drugs Market: Country Analysis

14.7. UK Brain Tumor Drugs Market

14.8. UK Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.9. UK Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.10. UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.11. UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.12. Germany Brain Tumor Drugs Market

14.13. Germany Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.14. Germany Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.15. Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.16. Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.17. France Brain Tumor Drugs Market

14.18. France Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.19. France Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.20. France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.21. France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Brain Tumor Drugs Market

15.1. Eastern Europe Brain Tumor Drugs Market Overview

15.1.1. Region Information

15.1.2. Impact Of COVID-19

15.1.3. Market Information

15.1.4. Background Information

15.1.5. Government Initiatives

15.1.6. Regulations

15.1.7. Regulatory Bodies

15.1.8. Major Associations

15.1.9. Taxes Levied

15.1.10. Corporate Tax Structure

15.1.11. Investments

15.1.12. Major Companies

15.2. Eastern Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.3. Eastern Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.4. Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.5. Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.6. Eastern Europe Brain Tumor Drugs Market: Country Analysis

15.7. Russia Brain Tumor Drugs Market

15.8. Russia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.9. Russia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.10. Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.11. Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16. North America Brain Tumor Drugs Market

16.1. North America Brain Tumor Drugs Market Overview

16.1.1. Region Information

16.1.2. Impact Of COVID-19

16.1.3. Market Information

16.1.4. Background Information

16.1.5. New Drug Approvals

16.1.6. Government Initiatives

16.1.7. Regulations

16.1.8. Regulatory Bodies

16.1.9. Major Associations

16.1.10. Taxes Levied

16.1.11. Corporate Tax Structure

16.1.12. Investments

16.1.13. Major Companies

16.2. North America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.3. North America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.4. North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.5. North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.6. North America Brain Tumor Drugs Market: Country Analysis

16.7. USA Brain Tumor Drugs Market

16.8. USA Brain Tumor Drugs Market Overview

16.8.1. Country Information

16.8.2. Impact Of COVID-19

16.8.3. Market Information

16.8.4. Background Information

16.8.5. New Drug Approvals

16.8.6. Government Initiatives

16.8.7. Regulations

16.8.8. Regulatory Bodies

16.8.9. Major Associations

16.8.10. Corporate Tax Structure

16.8.11. Investments

16.8.12. Major Companies

16.9. USA Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.10. USA Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.11. USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.12. USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17. South America Brain Tumor Drugs Market

17.1. South America Brain Tumor Drugs Market Overview

17.1.1. Region Information

17.1.2. Impact Of COVID-19

17.1.3. Market Information

17.1.4. Background Information

17.1.5. Government Initiatives

17.1.6. Regulations

17.1.7. Regulatory Bodies

17.1.8. Major Associations

17.1.9. Taxes Levied

17.1.10. Corporate Tax Structure

17.1.11. Investments

17.1.12. Major Companies

17.2. South America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.3. South America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.4. South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.5. South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.6. South America Brain Tumor Drugs Market: Country Analysis

17.7. Brazil Brain Tumor Drugs Market

17.8. Brazil Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.9. Brazil Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.10. Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.11. Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Brain Tumor Drugs Market

18.1. Middle East Brain Tumor Drugs Market Overview

18.1.1. Region Information

18.1.2. Impact Of COVID-19

18.1.3. Market Information

18.1.4. Background Information

18.1.5. New Drug Approvals

18.1.6. Government Initiatives

18.1.7. Regulations

18.1.8. Regulatory Bodies

18.1.9. Major Associations

18.1.10. Taxes Levied

18.1.11. Corporate Tax Structure

18.1.12. Investments

18.1.13. Major Companies

18.2. Middle East Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

18.3. Middle East Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

18.4. Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18.5. Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19. Africa Brain Tumor Drugs Market

19.1. Africa Brain Tumor Drugs Market Overview

19.1.1. Region Information

19.1.2. Impact Of COVID-19

19.1.3. Market Information

19.1.4. Background Information

19.1.5. Government Initiatives

19.1.6. Regulations

19.1.7. Regulatory Bodies

19.1.8. Major Associations

19.1.9. Taxes Levied

19.1.10. Corporate Tax Structure

19.1.11. Investments

19.1.12. Major Companies

19.2. Africa Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.3. Africa Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.4. Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.5. Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20. Brain Tumor Drugs Global Market Competitive Landscape

20.1. Company Profiles

20.2. F. Hoffmann-La Roche Ltd

20.2.1. Company Overview

20.2.2. Products And Services

20.2.3. Business Strategy

20.2.4. Financial Overview

20.3. Novartis AG

20.3.1. Company Overview

20.3.2. Products And Services

20.3.3. Business Strategy

20.3.4. Financial Overview

20.4. Amgen Inc.

20.4.1. Company Overview

20.4.2. Products And Services

20.4.3. Business Strategy

20.4.4. Financial Overview

20.5. Pfizer Inc.

20.5.1. Company Overview

20.5.2. Products And Services

20.5.3. Business Strategy

20.5.4. Financial Overview

20.6. Merck & Co., Inc.

20.6.1. Company Overview

20.6.2. Products And Services

20.6.3. Business Strategy

20.6.4. Financial Overview

21. Brain Tumor Drugs Pipeline Analysis

22. Key Mergers And Acquisitions In The Brain Tumor Drugs Market

22.1. Pfizer To Acquire Trillium Therapeutics INC.

22.2. Chimerix Acquired Oncoceutics

22.3. Century Therapeutics Acquired Empirica Therapeutics

22.4. Kintara Therapeutics Merged With Adgero Biopharmaceuticals

22.5. CNS Pharmaceuticals Acquired Houston Pharmaceuticals

22.6. TRIGR Therapeutics Collaborated With ABL Bio

23. Global Brain Tumor Drugs Market Opportunities And Strategies

23.1. Global Brain Tumor Drugs Market In 2025 – Countries Offering Most New Opportunities

23.2. Global Brain Tumor Drugs Market In 2025 – Segments Offering Most New Opportunities

23.3. Global Brain Tumor Drugs Market In 2025 – Growth Strategies

23.3.1. Market Trend Based Strategies

23.3.2. Competitor Strategies

24. Appendix

24.1. Market Data Sources

24.2. Research Methodology

24.3. Currencies

24.4. Research Inquiries

24.5. The Business Research Company

24.6. Copyright and Disclaimer

List Of Tables

Table 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 4: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 5: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 6: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 7: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 8: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 9: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 10: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 11: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals

Table 12: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 13: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands

Table 14: Asia-Pacific Brain Tumor Drugs Market , Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 15: Asia-Pacific, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 16: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 17: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 18: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 19: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 20: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 21: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 22: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 23: China Vaccine Market, COVID-19 Vaccines Approvals

Table 24: China, Population By Age Group, 2015-2025, Thousands

Table 25: China Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $

Table 26: China, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 27: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 28: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 29: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 30: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 31: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 32: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 33: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 34: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 35: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 36: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 37: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 38: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 39: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 40: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 41: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 42: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 43: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 44: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 45: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 46: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 47: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 48: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 49: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 50: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 51: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 52: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 53: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 54: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 55: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 56: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 57: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 58: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 59: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 60: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 61: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 62: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 63: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 64: Western Europe Vaccine Market, COVID-19 Vaccines Approvals

Table 65: Western Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 66: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands

Table 67: Western Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 68: Western Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 69: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 70: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 71: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 72: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 73: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 74: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 75: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 76: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 77: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 78: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 79: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 80: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 81: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 82: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 83: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 84: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 85: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 86: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 87: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 88: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 89: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 90: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 91: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 92: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 93: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 94: Western Europe Vaccine Market, COVID-19 Vaccines Approvals

Table 95: Eastern Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 96: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands

Table 97: Eastern Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 98: Eastern Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 99: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 100: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 101: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 102: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 103: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 104: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 105: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 106: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 107: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 108: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 109: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 110: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 111: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 112: North America Vaccine Market, COVID-19 Vaccines Approvals

Table 113: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 114: North America, Population By Age Group, By Country, 2015-2025, Thousands

Table 115: North America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 116: North America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 117: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 118: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 119: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 120: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 121: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 122: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 123: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 124: USA Vaccine Market, COVID-19 Vaccines Approvals

Table 125: USA, Population By Age Group, 2015-2025, Thousands

Table 126: USA Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $

Table 127: USA Home, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 128: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 129: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 130: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 131: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 132: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 133: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 134: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 135: South America Vaccine Market, COVID-19 Vaccines Approvals

Table 136: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 137: South America, Population By Age Group, By Country, 2015-2025, Thousands

Table 138: South America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 139: South America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 140: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 141: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 142: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 143: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 144: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 145: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 146: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 147: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 148: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 149: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 150: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 151: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 152: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 153: Middle East Vaccine Market, COVID-19 Vaccines Approvals

Table 154: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 155: Middle East, Population By Age Group, By Country, 2015-2025, Thousands

Table 156: Middle East Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 157: Middle East Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 158: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 159: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 160: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 161: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 162: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 163: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 164: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 165: Africa Vaccine Market, COVID-19 Vaccines Approvals

Table 166: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country

Table 167: Africa, Population By Age Group, By Country, 2015-2025, Thousands

Table 168: Africa Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 169: Africa Oncology Drugs Market Size, By Country, 2015-2025, $ Billion

Table 170: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion

Table 171: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Table 172: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 173: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 174: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 175: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 176: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 177: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Table 178: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion

Table 179: Novartis AG – Financial Performance, 2016 – 2020, $ Billion

Table 180: Amgen Inc. – Financial Performance, 2016 – 2020, $ Billion

Table 181: Pfizer Inc. – Financial Overview, 2016 - 2020, $ Billion

Table 182: Merck & Co., Inc. – Financial Performance, 2016 - 2020, $ Billion

Table 183: Global Brain Tumor Drugs Market, Pipeline Analysis

Table 184: Global Brain Tumor Drugs Market Size Gain ($ Million), 2020 – 2025, By Country

Table 185: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By Drugs, 2020 – 2025

Table 186: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By End-User, 2020 – 2025

Table 187: Brain Tumor Drugs- Market Data Sources

List Of Figures

Figure 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 4: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 5: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 6: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 7: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 8: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 9: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 11: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 12: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 13: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 15: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 16: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 17: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 18: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 19: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 20: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 21: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 22: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 23: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 24: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 27: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 28: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 29: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 30: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 31: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 32: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 33: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 34: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 35: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 36: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 37: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 38: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 39: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 40: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 41: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 42: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 43: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 44: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 45: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 46: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 47: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 48: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 49: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 50: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 51: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 52: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 53: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 54: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 55: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 56: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 57: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 58: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 59: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 60: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 61: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 62: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 63: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 64: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 65: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 66: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 67: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 68: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 69: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 70: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 71: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 72: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 73: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 74: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 75: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 76: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 77: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 78: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 79: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million

Figure 80: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 81: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 82: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 83: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 84: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion

Figure 85: Novartis AG – Financial Performance, 2016 – 2020, $ Billion

Figure 86: Amgen Inc. – Financial Performance, 2016 – 2020, $ Billion

Figure 87: Pfizer Inc. – Financial Overview, 2016 – 2020, $ Billion

Figure 88: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oligonucleotide Therapy Global Market Report 2024 – By Type (Antisense Oligonucleotide, Aptamer, Other Types), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User), By End User (Hospitals, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

HIV Drugs Global Market Report 2024 – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types), By Administration (Oral, Parenteral), By Application (Hospital Pharmacies, Retail Pharmacies, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antidepressants Global Market Report 2024 – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)), By Drug Class (Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants), By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder) – Market Size, Trends, And Global Forecast 2024-2033

View Report